The New York TimesAlzheimer’s Drug May Benefit Some Patients, New Data Shows (Published 2022)Nov 29, 2022By Pam BelluckMore
STATAnti-amyloid drugs and the mystery of treatment-associated brain shrinkageNov 28, 2022By Madhav ThambisettyMore
Science | AAASSecond death linked to potential antibody treatment for Alzheimer’s diseaseNov 27, 2022By Charles PillerMore
The GuardianNHS ‘nowhere near ready’ to deliver new Alzheimer’s drug, doctors sayNov 30, 2022By Ian SampleMore
NPRStudy: Alzheimer's drug shows modest success slowing declines in memory, thinkingNov 30, 2022By Jon HamiltonMore
ReutersAlzheimer's drug from Eisai and Biogen slows cognitive decline, side-effects in focusNov 30, 2022By Deena BeasleyMore
The Washington PostAlzheimer’s drug shows promise but needs more study for safety, researchers sayNov 30, 2022By Daniel GilbertMore
CNNExperimental drug appears to slow progression of Alzheimer’s disease in clinical trial but raises safety concernsNov 30, 2022By Jacqueline HowardMore